NCT00201435View on ClinicalTrials.gov

Weekly Taxol Plus Xeloda® vs Taxotere q3wk Plus Xeloda® in the Treatment of Metastatic BC

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

224

Participants

Timeline

Start Date

March 31, 2005

Primary Completion Date

January 31, 2008

Study Completion Date

May 31, 2008

Conditions
Breast Neoplasm
Interventions
DRUG

Paclitaxel weekly in combination with capecitabine

DRUG

Docetaxel every 3 week in combination with capecitabine

Trial Locations (1)

0407

Ullevål university hospital, Oslo

All Listed Sponsors
lead

Norwegian Breast Cancer Group

OTHER

NCT00201435 - Weekly Taxol Plus Xeloda® vs Taxotere q3wk Plus Xeloda® in the Treatment of Metastatic BC | Biotech Hunter | Biotech Hunter